Sonida Senior Living, Inc. SNDA R2K

Healthcare · Medical Care Facilities · United States

https://www.sonidaseniorliving.com

Sonida Senior Living, Inc. owns and operates senior housing communities in the United States. The company provides independent living services, which include daily meals, transportation, social and recreational activities, laundry, housekeeping, and 24-hour staffing; and access to health screenings, periodic special services, and dietary and similar programs, as well as exercise and fitness classes. It offers assisted living services consist of personal care services, such as assistance with activities of daily living, including ambulation, bathing, dressing, eating, grooming, personal hygiene, and monitoring or assistance with medications; support services, such as meals, assistance with social and recreational activities, laundry, general housekeeping, maintenance, and transportation services; and supplemental services, which include extra transportation, personal maintenance, and extra laundry services, as well as special care services for residents with various forms of dementia. In addition, it offers memory care services; and home care services through third-party providers, such as customized physician, dentistry, podiatry, and other health-related rehabilitation and therapy services. Further, it provides respite care and temporary care and therapy programs. The company was formerly known as Capital Senior Living Corporation and changed its name to Sonida Senior Living, Inc. in November 2021. Sonida Senior Living, Inc. was founded in 1990 and is based in Dallas, Texas.

Market & Price

Market Cap

$1.67B

Current Price

$35.35

High / Low (52W)

$38.78 / $23.92

Beta

0.82

Valuation

Stock P/E

Industry PE

23.65

Forward P/E

PEG Ratio

2.04

Book Value

$18.95

Price to Book

1.86

P/S

4.56

EV/EBITDA

65.03

Dividend Yield

Profitability & Returns

ROCE

-4.53%

ROE

-20.08%

ROA

-0.51%

Profit Margin

-27.08%

Op Margin

-3.03%

EPS (Latest Qtr)

$-2.39

EPS (TTM)

$-5.84

Balance Sheet & Liquidity

Debt/Equity

1.82

Quick Ratio

0.33

Current Ratio

0.44

Debt

$1.62B

Total Assets

$844.85M

Current Assets

$77.88M

Working Capital

$-27.25M

Ownership

Promoter Holding

9.85%

Chg in Prom Hold

FII / Inst Holding

57.67%

Chg in FII Hold

Financial Snapshot

Enterprise Value

$3.19B

Total Revenue (TTM)

$367.34M

EBITDA

$49.08M

Free Cash Flow

$39.80M

Operating Cash Flow

$-15.35M

Shares Outstanding

47.35M

Gross Margin

25.01%

Payout Ratio

0.00%

Growth (CAGR)

Revenue 5Y

16.92%

Profit 5Y

-10.04%

Revenue (YoY)

38.50%

Earnings (YoY)

PROS

Compounding revenue at 16.9% over 5 years.
Generates positive free cash flow.
In a confirmed uptrend (50-DMA above 200-DMA).

CONS

Earnings shrank at -10.0% CAGR over 5 years.

* The pros and cons are auto-generated from financial metrics.

Price Chart

Robinhood TradingView StockAnalysis

Fundamental Growth

Period: Metric:

Figures from the latest reported periods. CAGR is computed across the displayed window (quarterly CAGR is annualised assuming 4 quarters per year).

Peer comparison

Peer companies in the same sector (Healthcare).

#	Name	CMP $	P/E	Mkt Cap	Div Yld %	ROCE %	ROE %	Rev CAGR 5Y %	Profit CAGR 5Y %
1	SNDA Sonida Senior Living, Inc. R2K	35.35	-	$1.67B	-	-4.53%	-20.08%	16.92%	-10.04%
2	LLY Eli Lilly and Company SPX	1,105.00	39.21	$985.37B	0.63%	38.44%	107.46%	31.69%	48.96%
3	JNJ Johnson & Johnson SPX	225.33	26.11	$542.42B	2.38%	23.13%	26.42%	5.60%	14.32%
4	UNH UnitedHealth Group Incorporated SPX	380.31	28.66	$345.38B	2.32%	9.60%	12.18%	11.35%	-15.69%
5	MRK Merck & Co., Inc. SPX	118.72	33.44	$293.22B	2.86%	20.66%	18.94%	3.12%	7.93%
6	TMO Thermo Fisher Scientific Inc. SPX	492.51	27.11	$183.03B	0.38%	9.17%	13.52%	-0.27%	-1.19%
7	AMGN Amgen Inc. NDXSPX	336.79	23.42	$181.77B	2.99%	18.02%	101.32%	11.77%	5.58%
8	GILD Gilead Sciences, Inc. NDXSPX	134.43	18.29	$166.90B	2.44%	22.92%	43.36%	2.57%	22.83%
9	ISRG Intuitive Surgical, Inc. NDXSPXAI	424.64	51.53	$150.39B	-	15.96%	17.23%	17.39%	29.26%

Quarterly Results

Figures in USD.

Metric	Jun 2015	Sep 2015	Dec 2015	Mar 2016	Jun 2016	Sep 2016	Dec 2016	Mar 2017	Jun 2017	Sep 2017	Dec 2017	Mar 2018	Jun 2018	Sep 2018	Dec 2018	Mar 2019	Jun 2019	Sep 2019	Dec 2019	Mar 2020	Jun 2020	Sep 2020	Mar 2021	Jun 2021	Sep 2021	Mar 2022	Jun 2022	Sep 2022	Mar 2023	Jun 2023	Sep 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Revenue	-	-	-	-	-	-	-	115.99M	116.72M	117.32M	116.97M	114.64M	114.63M	115.65M	115.10M	114.18M	113.13M	111.11M	108.69M	106.13M	101.48M	96.05M	61.65M	57.54M	57.92M	-	-	-	-	-	-	-	-	-	-	91.92M	93.53M	98.04M	97.66M	122.63M
Cost of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	11.61M	71.97M	77.44M	-176.68M	12.41M
Gross Profit	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	80.32M	21.56M	20.59M	274.33M	110.22M
Operating Expenses	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	82.57M	23.38M	25.16M	279.15M	113.10M
Operating Income	3.68M	5.68M	-	4.15M	5.79M	3.69M	-	-9.61M	4.69M	4.51M	-	5.39M	3.64M	1.70M	-	1.97M	203.00K	-8.11M	-	-	-	-	-	-	-	-	-	-	-	-	-	14.91M	-	-	-	-2.26M	-1.82M	-4.56M	-4.82M	-2.88M
EBITDA	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	10.18M	21.04M	-2.72M	-5.25M	-8.45M
Interest Expense	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	9.45M	9.27M	9.91M	10.01M	12.83M
Pretax Income	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-12.95M	-1.88M	-27.26M	-30.07M	-41.24M
Tax Provision	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	75.00K	91.00K	88.00K	76.00K	208.00K
Net Income	-5.17M	2.87M	-5.95M	-5.98M	-4.45M	-7.08M	-10.51M	-21.84M	-7.83M	-8.13M	-6.36M	-7.16M	-9.06M	-11.09M	-26.29M	-12.98M	-12.53M	-20.73M	10.22M	-47.18M	-12.75M	-214.96M	38.84M	49.08M	36.51M	-16.68M	-7.41M	-13.74M	24.14M	-12.21M	-18.41M	27.02M	-9.82M	-	-	-12.53M	-1.56M	-26.91M	-29.78M	-41.23M
Diluted EPS	-0.18	0.10	-0.21	-0.21	-0.15	-0.24	-0.36	-750.00	-270.00	-280.00	-220.00	-0.24	-0.30	-0.37	-0.88	-0.43	-0.41	-0.68	0.34	-23.28	-6.25	-104.91	18.80	23.49	17.48	-2.81	-1.34	-2.34	2.76	-2.11	-2.79	2.16	-0.86	-	-	-0.77	-0.16	-1.56	-1.72	-2.39

Profit & Loss (Annual)

Figures in USD.

Metric	Dec 2009	Dec 2010	Dec 2011	Dec 2012	Dec 2013	Dec 2014	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Revenue	-	-	-	-	-	-	-	447.45M	467.00M	460.02M	447.10M	383.86M	-	238.43M	255.32M	304.33M	381.14M
Cost of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	27.37M	21.10M	33.10M	44.75M
Gross Profit	-	-	-	-	-	-	-	-	-	-	-	-	-	211.06M	234.22M	271.23M	336.39M
Operating Expenses	-	-	-	-	-	-	-	-	-	-	-	-	-	240.37M	249.41M	280.19M	349.84M
Operating Income	16.61M	18.52M	17.91M	13.65M	11.25M	13.90M	18.84M	14.39M	7.84M	7.60M	-14.69M	-	-	-29.31M	-15.19M	-8.96M	-13.45M
EBITDA	-	-	-	-	-	-	-	-	-	-	-	-	-	17.16M	55.15M	78.00M	23.24M
Interest Expense	-	-	-	-	-	-	-	-	-	-	-	-	-	33.02M	36.12M	36.99M	38.63M
Pretax Income	-	-	-	-	-	-	-	-	-	-	-	-	-	-54.31M	-20.85M	-3.04M	-72.16M
Tax Provision	-	-	-	-	-	-	-	-	-	-	-	-	-	86.00K	253.00K	239.00K	330.00K
Net Income	2.76M	4.25M	3.02M	-3.12M	-16.50M	-24.13M	-14.28M	-28.02M	-44.17M	-53.60M	-36.03M	-295.37M	-	-54.40M	-21.11M	-2.06M	-70.78M
Diluted EPS	0.10	0.16	0.11	-0.11	-0.58	-0.83	-0.50	-0.97	-1.50	-26.97	-17.87	-144.08	18.93	-9.27	-3.85	-0.54	-

Compounded Sales Growth

5 Years:	16.92%
1 Year:	38.50%

Compounded Profit Growth

5 Years:	-10.04%
1 Year:	-

Stock Price Performance

1 Year:	+44.88%
6 Months:	+6.57%
3 Months:	-1.50%
1 Month:	-5.73%

Balance Sheet (Annual)

Figures in USD.

Metric	Dec 2008	Dec 2009	Dec 2010	Dec 2011	Dec 2012	Dec 2013	Dec 2014	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Total Assets	-	-	382.78M	462.33M	636.94M	745.55M	891.37M	1.02B	1.15B	1.18B	1.15B	1.27B	702.83M	-	661.27M	621.46M	841.92M	844.85M
Current Assets	-	-	-	-	-	-	-	-	-	-	-	-	-	-	43.57M	32.34M	64.09M	77.88M
Cash & Equivalents	25.88M	28.97M	31.25M	22.28M	18.74M	13.61M	39.21M	56.09M	34.03M	17.65M	31.31M	23.98M	17.89M	-	16.91M	4.08M	16.99M	11.01M
Inventory	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Receivables	-	-	-	-	-	-	-	-	-	-	-	-	-	-	6.11M	8.02M	18.96M	18.61M
Total Liabilities	-	-	-	-	-	-	-	-	-	-	-	-	982.10M	-	719.43M	688.01M	712.31M	788.59M
Current Liabilities	-	-	32.40M	40.21M	62.15M	58.70M	99.46M	70.54M	81.39M	87.00M	85.03M	129.03M	373.12M	-	94.32M	100.86M	75.61M	105.13M
Long Term Debt	-	-	-	-	-	-	-	-	-	-	-	-	604.73M	-	625.00M	587.10M	635.90M	682.45M
Total Debt	-	-	-	-	-	-	-	-	-	-	-	-	-	-	671.03M	629.42M	651.39M	689.74M
Total Equity	155.15M	158.13M	163.82M	169.14M	168.59M	157.95M	141.17M	135.75M	116.92M	80.43M	35.27M	14.38M	-279.26M	-	-58.16M	-66.55M	123.03M	51.24M
Shares Outstanding	-	-	-	-	-	-	-	-	-	-	-	-	-	-	6.67M	8.18M	18.99M	18.77M

Cash Flows (Annual)

Figures in USD.

Metric	Dec 2009	Dec 2010	Dec 2011	Dec 2012	Dec 2013	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Operating Cash Flow	19.64M	15.55M	14.08M	46.40M	42.64M	52.28M	55.59M	36.87M	5.23M	-6.79M	-	-2.58M	10.68M	-1.78M	24.36M
Investing Cash Flow	-7.30M	-5.28M	-77.44M	-190.62M	-162.30M	-201.05M	-124.94M	-21.91M	47.78M	8.51M	-	-36.90M	-16.56M	-208.92M	-70.69M
Financing Cash Flow	-9.24M	-7.99M	54.39M	140.67M	114.53M	126.85M	53.05M	-1.67M	-60.26M	-15.92M	-	-22.65M	-7.11M	232.04M	37.51M
Capital Expenditure	-	-	-	-	-	-	-	-	-	-	-	-24.56M	-17.94M	-25.17M	-33.28M
Free Cash Flow	-	-	-	-	-	-	-	-	-	-	-	-27.14M	-7.25M	-26.95M	-8.92M
Net Change in Cash	-	-	-	-	-	-	-	-	-	-	-	-62.13M	-12.99M	21.34M	-8.81M
Share Buybacks	934.00K	-	-	-	-	2.50M	-	-	-	-	-	-	-	-	-

Ratios (Annual)

Figures in %.

Metric	Dec 2009	Dec 2010	Dec 2011	Dec 2012	Dec 2013	Dec 2014	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Gross Margin %	-	-	-	-	-	-	-	-	-	-	-	-	-	88.5%	91.7%	89.1%	88.3%
Operating Margin %	-	-	-	-	-	-	-	3.2%	1.7%	1.7%	-3.3%	-	-	-12.3%	-5.9%	-2.9%	-3.5%
Net Margin %	-	-	-	-	-	-	-	-6.3%	-9.5%	-11.7%	-8.1%	-76.9%	-	-22.8%	-8.3%	-0.7%	-18.6%
ROE %	1.7%	2.6%	1.8%	-1.9%	-10.4%	-17.1%	-10.5%	-24.0%	-54.9%	-152.0%	-250.6%	105.8%	-	93.5%	31.7%	-1.7%	-138.1%
ROCE %	-	5.3%	4.2%	2.4%	1.6%	1.8%	2.0%	1.4%	0.7%	0.7%	-1.3%	-	-	-5.2%	-2.9%	-1.2%	-1.8%

Shareholding Pattern

Insiders

9.85%

Institutions

57.67%

Public Float

63.98%

Top Institutional Holders

#	Holder	% Held	Shares	Value
1	Conversant Capital LLC	30.85%	14.61M	$516.32M
2	Capital International Investors	3.68%	1.74M	$61.64M
3	Irenic Capital Management LP	2.58%	1.22M	$43.12M
4	Hazelview Securities Inc.	1.41%	668.65K	$23.64M
5	J. Goldman & Co., L.P.	1.16%	550.68K	$19.47M
6	Solas Capital Management, LLC	0.94%	445.88K	$15.76M
7	Blackrock Inc.	0.90%	424.51K	$15.01M
8	Vanguard Capital Management LLC	0.77%	363.74K	$12.86M
9	Clayton Partners, LLC	0.66%	311.08K	$11.00M
10	Jane Street Group, LLC	0.58%	273.43K	$9.67M

Analyst View

Loading analyst coverage…

Latest News

Recent headlines for SNDA

No recent headlines available.

SNDA · Healthcare